SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* McDearis Kevin (Last) (First) (Middle) 65 FAIRCHILD STREET (Street) CHARLESTON SC 29492 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/09/2020	3. Issuer Name and Ticker or Trading Symbol BLACKBAUD INC [ BLKB ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Products Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	57,910	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

See Exhibit 99.1.

	/s/ S. Halle Vakani, Attorney-in-Fact	01/11/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

	POWER OF ATTORNEY

	Known all by these presents, that the undersigned hereby constitutes and
appoints each of Anthony Boor, Jon Olson, Donald R. Reynolds and S. Halle
Vakani, and each of them acting alone, signing singly, the undersigned's true
and lawful attorney-in-fact to:  (1) execute for and on behalf of the
undersigned, in the undersigned's capacity as an officer, director and/or 10% or
more stockholder of Blackbaud, Inc. (the "Company"), Forms ID, 3, 4, 5, and
Update Passphrase Acknowledgement (and any amendments thereto) in accordance
with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934
Act") and Schedules 13D and/or Schedules 13G (and any amendments thereto) in
accordance with the 1934 Act, and the rules promulgated thereunder; (2) do and
perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Form ID, 3, 4, 5, and
Update Passphrase Acknowledgement and Schedules 13D and/or Schedules 13G (and
any amendments thereto) and to file timely such form with the United States
Securities and Exchange Commission and any stock exchange or similar authority;
and (3) take any other action of any type whatsoever in connection with the
foregoing which in the opinion of such attorney-in-fact may be of benefit to, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming that all such attorneys-in-fact, or such
attorneys-in-facts' substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the 1934 Act.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms ID, 3, 4 and 5 and Schedules 13D
and Schedules 13G with respect to the undersigned's holdings of and transactions
in securities issued by the Company, unless earlier revoked by the undersigned
in a signed writing delivered to each of the foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 15th day of December 2020.


/s/ Kevin McDearis
Kevin McDearis

Remarks:

Mr. McDearis' non-derivative securities owned beneficially comprise the
following securities:

(a) 10,980 shares of restricted stock ("RS") were granted on August 11, 2014 and
vested in 4 equal annual installments beginning on August 11, 2015 (4,586 of the
resulting shares were withheld to satisfy tax liabilities incurred upon vesting
and 6,394 have been sold); (b) 13,690 shares of RS were granted on February 13,
2015 and vested in 4 equal annual installments beginning on February 13, 2016
(5,785 of the resulting shares were withheld to satisfy tax liabilities incurred
upon vesting and 7,905 have been sold); (c) 10,980 performance restricted stock
units ("PRSUs") were earned on August 11, 2015 upon the vesting of a percentage
of PRSUs granted August 11, 2014 upon the Issuer's achievement of performance
goals for the period ended December 31, 2014 (4,817 of the resulting shares were
withheld to satisfy tax liabilities incurred upon vesting and 4,270 have been
sold); (d) 20,600 shares of RS were granted on February 11, 2016 and vested in 4
equal annual installments beginning on February 11, 2017 of which 1,102 shares
of vested RS are held (8,297 of the resulting shares were withheld to satisfy
tax liabilities incurred upon vesting and 11,201 have been sold); (e) 13,689
PRSUs were earned on February 13, 2016 upon the vesting of a percentage of PRSUs
granted February 13, 2015 upon the Issuer's achievement of performance goals for
the period ended December 31, 2015 (5,917 of the resulting shares were withheld
to satisfy tax liabilities incurred upon vesting and 5,894 have been sold); (f)
15,124 shares of RS were granted on February 14, 2017 vesting in 4 equal annual
installments beginning on February 14, 2018 (3/4 of the resulting shares are
vested, of which 5,259 of the resulting shares were withheld to satisfy tax
liabilities incurred upon vesting and 6,084 have been sold); (g) 20,600 PRSUs
were earned on February 14, 2017 upon the vesting of a percentage of PRSUs
granted February 11, 2016 upon the Issuer's achievement of performance goals for
the period ended December 31, 2016 (7,894 of the resulting shares were withheld
to satisfy tax liabilities incurred upon vesting and 7,401 have been sold); (h)
10,551 shares of RS were granted on February 12, 2018 vesting in 4 equal annual
installments beginning on February 12, 2019 (1/2 of the resulting shares are
vested, of which 2,420 of the resulting shares were withheld to satisfy tax
liabilities incurred upon vesting and 2,855 have been sold); (i) 13,060 PRSUs
were earned on February 14, 2018 upon the vesting of a percentage of PRSUs
granted February 14, 2017 upon the Issuer's achievement of performance goals for
the period ended December 31, 2017 (6,055 of the resulting shares were withheld
to satisfy tax liabilities incurred upon vesting and 5,855 have been sold); (j)
6,681 PRSUs were earned on February 12, 2019 upon the vesting of a percentage of
PRSUs granted February 12, 2018 upon the Issuer's achievement of performance
goals for the period ended December 31, 2018 (2/3 of the resulting shares are
vested, of which 2,043 of the resulting shares were withheld to satisfy tax
liabilities incurred upon vesting, 2,411 have been sold and the remaining shares
will vest on February 12, 2021); (k) 15,235 shares of RS were granted on
February 12, 2019 vesting in 4 equal annual installments beginning February 12,
2020 (1/4 of the resulting shares are vested, of which 1,727 of the resulting
shares were withheld to satisfy tax liabilities incurred upon vesting and 2,081
have been sold); (l) 16,639 PRSUs were earned on February 12, 2020 upon the
vesting of a percentage of PRSUs granted February 12, 2019 upon the Issuer's
achievement of performance goals for the period ended December 31, 2019 (1/3 of
the resulting shares are vested, of which 2,572 of the resulting shares were
withheld to satisfy tax liabilities incurred upon vesting, 2,975 have been sold,
and the remaining shares will vest in two equal annual installments beginning on
February 12, 2021); (m) 12,530 shares of RS were granted on February 12, 2020
vesting in 4 equal annual installments beginning on February 12, 2021; and (n)
248 restricted stock units ("RSUs") were granted on May 1, 2020 and will vest in
full on May 1, 2021.

The vesting of all RSUs are subject to the Reporting Person's continued
employment.